Manufacturing news briefs – stories you might have missed
Orthocell grants licence for bone regeneration in dental implant market Bone and tissue regeneration company Orthocell has signed a global exclusive licence and manufacturing agreement for its Striate+ resorbable collagen membrane product with leading dental implant company BioHorizons Implant Systems. In consideration for the licence, BioHorizons will pay Orthocell $23.1 million. Orthocell will supply BioHorizons…